NO20082875L - Fremgangsmate for produksjon av forbindelse merket med radioaktivt fluor - Google Patents

Fremgangsmate for produksjon av forbindelse merket med radioaktivt fluor

Info

Publication number
NO20082875L
NO20082875L NO20082875A NO20082875A NO20082875L NO 20082875 L NO20082875 L NO 20082875L NO 20082875 A NO20082875 A NO 20082875A NO 20082875 A NO20082875 A NO 20082875A NO 20082875 L NO20082875 L NO 20082875L
Authority
NO
Norway
Prior art keywords
preparing
radioactive fluorine
compound labeled
producing compound
tafdg
Prior art date
Application number
NO20082875A
Other languages
English (en)
Inventor
Keiichi Hirano
Daisaku Nakamura
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of NO20082875L publication Critical patent/NO20082875L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00—Other general methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av l8F-TAFDG som kan gi 18F-TAFDG i et høyt radiofluoreringsutbytte. En fremgangsmåte for fremstilling av en organisk forbindelse merket med radioaktivt fluor omfatter trinnene: fremstilling av en reaksjonsoppløsning inneholdende [18F]fluoridioner, en faseoverføringskatalysator, kaliumioner, l,3,4,6-tetra-0-acetyl-2-0-trifluorometansulfonyl-(3-D-mannopyranose som en merkingsforløperforbindelse og et oppløsningsmiddel; og å tilveiebringe en reaksjonsbetingelse for reaksjonsoppløsningen for å oppnå l,3,4,6-tetra-0-acetyl-2-[18F]fluoro-2-deoksyglukose, der oppløsningsmidlet inneholder vann.
NO20082875A 2005-12-06 2008-06-24 Fremgangsmate for produksjon av forbindelse merket med radioaktivt fluor NO20082875L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005352464 2005-12-06
PCT/JP2006/323933 WO2007066567A1 (ja) 2005-12-06 2006-11-30 放射性フッ素標識有機化合物の製造方法

Publications (1)

Publication Number Publication Date
NO20082875L true NO20082875L (no) 2008-08-28

Family

ID=38122713

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082875A NO20082875L (no) 2005-12-06 2008-06-24 Fremgangsmate for produksjon av forbindelse merket med radioaktivt fluor

Country Status (9)

Country Link
US (1) US20090281294A1 (no)
EP (1) EP1958954A4 (no)
JP (1) JP5106118B2 (no)
KR (1) KR20080074145A (no)
CN (1) CN101346392A (no)
AU (1) AU2006322673A1 (no)
CA (1) CA2632133A1 (no)
NO (1) NO20082875L (no)
WO (1) WO2007066567A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008029734A1 (fr) * 2006-09-06 2008-03-13 Nihon Medi-Physics Co., Ltd. Procédé de fabrication d'un composé organique marqué au fluor radioactif, et appareil et programme de synthèse correspondants
KR101430422B1 (ko) * 2010-04-08 2014-08-14 지멘스 메디컬 솔루션즈 유에스에이, 인크. 함수 유기 용매에서 18ｆ-표지된 트레이서의 합성
WO2016084193A1 (ja) * 2014-11-27 2016-06-02 国立大学法人東京工業大学 ６－デオキシ－６－放射性ヨード－ｄ－グルコースの製造方法、及びその方法に用いる高分子化合物
AU2020309307B2 (en) * 2019-07-09 2023-03-30 F. Hoffmann-La Roche Ag Process for the deprotection of oligonucleotides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2738224B2 (ja) 1992-06-15 1998-04-08 日本鋼管株式会社 １８ｆ標識有機化合物の製造法
US5264570A (en) * 1992-08-05 1993-11-23 General Electric Company Method for making 2-[18 F]fluoro-2-deoxy-D-glucose
BE1010280A3 (fr) 1996-05-02 1998-05-05 Coincidence S A Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose.
JP4979945B2 (ja) * 2003-09-30 2012-07-18 日本メジフィジックス株式会社 放射性フッ素化合物の製造方法
GB0425501D0 (en) * 2004-11-19 2004-12-22 Amersham Plc Fluoridation process

Also Published As

Publication number Publication date
US20090281294A1 (en) 2009-11-12
EP1958954A4 (en) 2009-12-30
CA2632133A1 (en) 2007-06-14
CN101346392A (zh) 2009-01-14
JP5106118B2 (ja) 2012-12-26
KR20080074145A (ko) 2008-08-12
EP1958954A1 (en) 2008-08-20
JPWO2007066567A1 (ja) 2009-05-14
AU2006322673A1 (en) 2007-06-14
WO2007066567A1 (ja) 2007-06-14

Similar Documents

Publication Publication Date Title
NO20082876L (no) Fremgangsmate for produksjon av forbindelse merket med radioaktivt fluor
WO2009018561A3 (en) Method for producing fluorinated organic compounds
NO20072570L (no) Framgangsmate for framstilling av organisk fluor forbindelser i alkoholholdige losningsmidler.
NO20082875L (no) Fremgangsmate for produksjon av forbindelse merket med radioaktivt fluor
IN2010DN02582A (no)
CN110054541B (zh) 一种氘代芳香族化合物的制备方法
WO2008090755A1 (ja) 光学活性α－フルオロカルボン酸エステルの製造方法
WO2015014031A1 (zh) 一种 (s)-3-( 二甲胺基 )-1-( 噻吩 -2- 基 )-1- 丙醇的生物制备方法
Ma et al. Access to 2-arylquinazolines via catabolism/reconstruction of amino acids with the insertion of dimethyl sulfoxide
EP1559705A4 (en) PRODUCTION OF HYDROXYBENZOIC ACIDS
WO2008096760A1 (ja) 新規ヘキサトリエン－β－カルボニル化合物
CN104788326A (zh) 一种盐酸氨溴索的合成方法
CN105801459B (zh) 一锅法制备芳基磺酸三氟甲硫酯系列化合物的方法
CN104478746B (zh) 一种dl-赖氨酸的制备方法
CN103045667A (zh) S-(+)-2-氨基丁酰胺盐酸盐的制备方法
CN114956934A (zh) 一种用于合成新型氘代氰基类化合物的中间体的制备方法
MXPA05003695A (es) Nuevo proceso para la sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y aplicacion en la sintesis de ivabradina y sales de adicion de la misma con un acido farmaceuticamente aceptable.
CN102690299B (zh) 一种串联反应制备三氯蔗糖-6-乙酸酯的方法
Ai et al. Chiral N‐Phosphonyl Imine Chemistry: Asymmetric Synthesis of α‐Alkyl β‐Amino Ketones by Reacting Phosphonyl Imines with Ketone‐Derived Enolates
CN107759506B (zh) 一种尼拉帕布中间体s-3-(4-溴苯基)哌啶的制备方法
CN101235037B (zh) 一种烷氧基卟啉的合成方法
CN112390696B (zh) 一种制备α-氨基腈的方法及其产品和应用
Berthelette et al. Base‐catalyzed deuterium and tritium labelling of 1‐biphenyl‐4‐ylpropane‐1, 2‐dione and deuteration of aryl methyl ketones
CN104233364A (zh) 一种光电催化co2合成甲醇的方法
Borzęcka et al. Biocatalyzed synthesis of both enantiopure fluoromisonidazole antipodes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application